Fracture infection – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 11:14:30 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Fracture infection – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on Clindamycin and Rifampicin for Treating Infections in Patients with Obesity, Fracture-Related Infections, Hidradenitis Suppurativa, or Prosthetic Joint Infections https://clinicaltrials.eu/trial/study-on-clindamycin-and-rifampicin-for-treating-infections-in-patients-with-obesity-fracture-related-infections-hidradenitis-suppurativa-or-prosthetic-joint-infections/ Wed, 29 Apr 2026 15:03:09 +0000 https://clinicaltrials.eu/trial/study-on-clindamycin-and-rifampicin-for-treating-infections-in-patients-with-obesity-fracture-related-infections-hidradenitis-suppurativa-or-prosthetic-joint-infections/ This clinical trial is focused on studying the treatment of certain infections using the medication clindamycin. The infections being studied include fracture-related infections, hidradenitis suppurativa (a skin condition that causes small, painful lumps under the skin), and prosthetic joint infections. The trial will also examine how the medication rifampicin and a person’s body weight might affect the treatment with clindamycin.

The purpose of the study is to understand how clindamycin is processed in the body and how effective it is when used alone or in combination with rifampicin. Participants will receive either clindamycin by itself or a combination of clindamycin and rifampicin. The study will monitor how the body absorbs and eliminates clindamycin, as well as the overall effectiveness of the treatment in curing the infections.

Participants will take the medication orally, and the study will last for a period of up to 12 weeks. The trial aims to gather information on how well the treatment works and to identify any factors that might influence its success, such as the participant’s weight or the use of additional medications like rifampicin. The ultimate goal is to improve treatment strategies for these infections.

]]>